frailty Flashcards

1
Q

what is the definition of frailty?

A

A distinctive health state related to the aging process in which multiple body systems gradually lose their in built reserves.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what are the concerns in frailty groups?

A

– Increased risk of deterioration –Worse outcomes from illness –Higher risk of acute hospital admission – Increased length of hospital stay – Care home admission –Death

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what are the concerns in frailty groups?

A

– Increased risk of deterioration –Worse outcomes from illness –Higher risk of acute hospital admission – Increased length of hospital stay – Care home admission –Death

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what are the concerns in frailty groups?

A

– Increased risk of deterioration –Worse outcomes from illness –Higher risk of acute hospital admission – Increased length of hospital stay – Care home admission –Death

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what are the concerns in frailty groups?

A

– Increased risk of deterioration –Worse outcomes from illness –Higher risk of acute hospital admission – Increased length of hospital stay – Care home admission –Death

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what are the concerns in frailty groups?

A

– Increased risk of deterioration –Worse outcomes from illness –Higher risk of acute hospital admission – Increased length of hospital stay – Care home admission –Death

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what are the concerns in frailty groups?

A

– Increased risk of deterioration –Worse outcomes from illness –Higher risk of acute hospital admission – Increased length of hospital stay – Care home admission –Death

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what are the concerns in frailty groups?

A

– Increased risk of deterioration –Worse outcomes from illness –Higher risk of acute hospital admission – Increased length of hospital stay – Care home admission –Death

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what are the concerns in frailty groups?

A

– Increased risk of deterioration –Worse outcomes from illness –Higher risk of acute hospital admission – Increased length of hospital stay – Care home admission –Death

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what are the concerns in frailty groups?

A

– Increased risk of deterioration –Worse outcomes from illness –Higher risk of acute hospital admission – Increased length of hospital stay – Care home admission –Death

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what are the concerns in frailty groups?

A

– Increased risk of deterioration –Worse outcomes from illness –Higher risk of acute hospital admission – Increased length of hospital stay – Care home admission –Death

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what are the concerns in frailty groups?

A

– Increased risk of deterioration –Worse outcomes from illness –Higher risk of acute hospital admission – Increased length of hospital stay – Care home admission –Death

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what are the concerns in frailty groups?

A

– Increased risk of deterioration –Worse outcomes from illness –Higher risk of acute hospital admission – Increased length of hospital stay – Care home admission –Death

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what are the concerns in frailty groups?

A

– Increased risk of deterioration –Worse outcomes from illness –Higher risk of acute hospital admission – Increased length of hospital stay – Care home admission –Death

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what are the concerns in frailty groups?

A

– Increased risk of deterioration –Worse outcomes from illness –Higher risk of acute hospital admission – Increased length of hospital stay – Care home admission –Death

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what are the concerns in frailty groups?

A

– Increased risk of deterioration –Worse outcomes from illness –Higher risk of acute hospital admission – Increased length of hospital stay – Care home admission –Death

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

how does someone with frailty often present?

A

– Falls – Immobility – Delirium
– Incontinence – Susceptibility to side-effects of medications

10
Q

what are the screening tools for frailty?

A
  • Electronic Frailty Index (eFI) – Enables GP’s to screen patients for frailty and its severity – An evidence based intervention to improve outcome
  • Rockwood Clinical Frailty Scale – Used with a hospital setting
11
Q

what does a comprehensive geriatric assessment consist of?

A

Multidisciplinary assessment of physical, psychological, functional and environmental factors
key- medication review

12
Q

how is polypharmacy clasified?

A

– Appropriate: prescribing for a patient with multiple conditions where
medication use is optimised and prescribed according to best
evidence
– Problematic: prescribing multiple medications inappropriately or
where the intended outcome of the medication is not achieved

13
Q

what is deprescribing? how does one stop it?

A

Process to ensure safe and effective withdrawal of inappropriate medication
tools:
STOP/START/STOPIT
NOTEARS
BEERS critera

14
Q

why do we worry about anticholinergic burden?

A

– Sedation – Constipation – Urinary retention – Blurred vision – All of these can increase the risk of confusion/delirium/falls in an
older patient.

15
Q

what effect may beta blockers have in a person with diabetes?

A

frequent hypoglycaemic episodes- there is a risk of masking hypoglycaemic symptoms

16
Q

what can thiazide diuretics mask?

A

exacerbating gout

17
Q

what should you do with digoxin with impaired renal function?

A

At doses ˃125 microgram per day with impaired renal funcƟon (eGFR ˂50ml/minute). Can be increased levels of toxicity (e.g. nausea, diarrhoea, arrhythmias)

18
Q

what dose of apixiban should be given in the elderly?

A

The recommended dose of apixaban is 2.5 mg taken orally twice daily in patients with NVAF and at least two of the following characteristics: age ≥ 80 years, body weight ≤ 60 kg, or serum
creatinine ≥ 133µmol/L

19
Q

what are some high risk combinations to avoid with NSAIDS?

A

– +ACE and ARB (+diuretic = ‘triple
whammy’) –
+existing renal disease –
+diagnosis of heart failure –
+warfarin –
+age >75 without PP

20
Q

what are some high risk drug combinations to avoid with warfarin?

A

– +antiplatelet
– HOWEVER check as may
be a genuine indication
– +NSAID
– +Macroline
– +Quinolone
– +Metronidazole
– +Azole antifungal

21
Q

what should be avoided following a heart failure diagnosis?

A

– +Glitazone
– +NSAID
– +Tricyclic antidepressant

22
Q

what drugs may it be necessary to withold in those who are dehydrated due to the risk of renal function?

A

– NSAIDs
– ACE/ARB
– Diuretics (take specialist advice if heart failure)
– Metformin
– This can be restarted when the patient improves

23
Q

give examples of drugs that are poorly tolerated in frail older people?

A
  • Digoxin in higher doses (i.e. over 250mcg)
  • Antipsychotics
  • Tricyclic antidepressants
  • Benzodiazepines
  • Antimuscarinics i.e solifenacin
  • Phenothiazines i.e. proclorperazine
  • Combination pain killers i.e. co-codamol
24
Q

what practical points are there relating to constipation in frail?

A

– Adequate fluid intake, diet, movement to reduce risk
– Ispaghula husk preparations should not be prescribed to patients with limited
mobility- risk of faecal impaction (adequate fluid intake also needed)
– Movicol has a high sodium content
– Excessive use of stimulant laxatives can cause electrolyte disturbance (low
potassium)

25
Q

what practical points are there relating to respiratory disease in frail?

A

– Ensure older patients can use their inhaled devices
– Ensure vaccination status up to date

26
Q

what key practical points is there relating to dementia?

A

– In general antipsychotics should not be used for behavioural and psychological
symptoms of dementia
– If antipsychotics are to be used in older people ensure appropriate dosage reduction

27
Q

what practical points are there for depression?

A

– Antidepressant should be continued for 6 weeks in order to determine the
effectiveness
– All antidepressants can cause hyponatraemia – this should be considered in all
patients who develop drowsiness, confusion or convulsions – SSRIs increase GI bleeding risk when prescribed with NSAIDs/steroids and other drugs with increase risk

28
Q

what key practical points should be given about bone health?

A

– Patients prescribed bisphosphonates should be prescribed calcium
and vitamin D
– check calcium levels to avoid hypercalcaemia – Consider vitamin D deficiency in all patients – therapeutic dose is
800mg/400iu daily
– Consider preferred formulations to increase compliance
– Revise how to counsel a patient on taking a bisphosphonate

29
Q

what key practical points should be given about hypertension?

A

– Target (without diabetes or CKD) is less than 150/90mmHg for people
over 80 years old
– CCB preferred (without diabetes) consider thiazide like diuretic if
have heart failure (or high risk of) or develops ankle oedema
– Initiate at lower doses and titrate slowly to avoid postural
hypotension
– Caution re ACE inhibitors and renal function – risk of AKI

30
Q

what should you look out for in thyroid disorders?

A

– Look out for the symptoms of over or under replacement

31
Q

what are the key practical points about pain?

A

– Consider risks and benefits carefully – Increased risks of opioid medication in older people
– Paracetamol – remember dose reduction if patient less than 50kg

32
Q

what key points are there about PD?

A

– Medications used to treat can contribute to confusion, constipation
and postural hypotension – monitoring and careful dosage
adjustment
– Remember the importance of timing of doses ‘get it in time’ rules

33
Q

what are they key points relating to urinary problems?

A

– Older people more prone to the antimuscarinic side effects of drugs
used to treat urinary incontinence
– People of child-bearing age should not handle finasteride or dutasteride tables/capsules – caution re dispensing and dosette
boxes